XTAE:KDST (Israel)  
Kadimastem Ltd logo

Kadimastem Ltd

₪ 1.37 (-0.15%) Dec 6
P/E:
At Loss
P/B:
6.10
Market Cap:
₪ 47.72M ($ 13.95M)
Enterprise V:
₪ 40.51M ($ 11.84M)
Volume:
24.75K
Avg Vol (2M):
29.27K
Also Trade In:
Volume:
24.75K
Market Cap ₪:
47.72M
Market Cap $:
13.95M
PE Ratio:
At Loss
Avg Vol (2-Month):
29.27K
Enterprise Value ₪:
40.51M
Enterprise Value $:
11.84M
PB Ratio:
6.10
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.
Name Current Vs Industry Vs History
Cash-To-Debt 1.91
Equity-to-Asset 0.36
Debt-to-Equity 1.02
Debt-to-EBITDA -0.34
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -4.33
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 54.71
9-Day RSI 54.77
14-Day RSI 54.19
6-1 Month Momentum % -27.24
12-1 Month Momentum % -70.84

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.4
Quick Ratio 1.4
Cash Ratio 1.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -52.7
Name Current Vs Industry Vs History
ROE % -338.55
ROA % -112.88
ROIC % -177.26
ROC (Joel Greenblatt) % -678.15
ROCE % -287.65

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₪)
EPS (TTM) (₪) -0.736
Beta 0
Volatility % 47.7
14-Day RSI 54.19
14-Day ATR (₪) 0.0901
20-Day SMA (₪) 1.3523
12-1 Month Momentum % -70.84
52-Week Range (₪) 1.084 - 4.05
Shares Outstanding (Mil) 34.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kadimastem Ltd Filings

Document Form Filing Date
No Filing Data

Kadimastem Ltd Analysis

Share your research